These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
125 related articles for article (PubMed ID: 23720813)
1. LIGHT (TNFSF14/CD258) is a decisive factor for recovery from experimental autoimmune encephalomyelitis. Maña P; Liñares D; Silva DG; Fordham S; Scheu S; Pfeffer K; Staykova M; Bertram EM J Immunol; 2013 Jul; 191(1):154-63. PubMed ID: 23720813 [TBL] [Abstract][Full Text] [Related]
2. Infiltration of Th1 and Th17 cells and activation of microglia in the CNS during the course of experimental autoimmune encephalomyelitis. Murphy AC; Lalor SJ; Lynch MA; Mills KH Brain Behav Immun; 2010 May; 24(4):641-51. PubMed ID: 20138983 [TBL] [Abstract][Full Text] [Related]
3. Expression of the HGF receptor c-met by macrophages in experimental autoimmune encephalomyelitis. Moransard M; Sawitzky M; Fontana A; Suter T Glia; 2010 Apr; 58(5):559-71. PubMed ID: 19941340 [TBL] [Abstract][Full Text] [Related]
4. Acceleration of experimental autoimmune encephalomyelitis in interleukin-10-deficient mice: roles of interleukin-10 in disease progression and recovery. Samoilova EB; Horton JL; Chen Y Cell Immunol; 1998 Sep; 188(2):118-24. PubMed ID: 9756642 [TBL] [Abstract][Full Text] [Related]
5. Roles of Sema4D-plexin-B1 interactions in the central nervous system for pathogenesis of experimental autoimmune encephalomyelitis. Okuno T; Nakatsuji Y; Moriya M; Takamatsu H; Nojima S; Takegahara N; Toyofuku T; Nakagawa Y; Kang S; Friedel RH; Sakoda S; Kikutani H; Kumanogoh A J Immunol; 2010 Feb; 184(3):1499-506. PubMed ID: 20038643 [TBL] [Abstract][Full Text] [Related]
6. T cell-independent modulation of experimental autoimmune encephalomyelitis in ADAP-deficient mice. Engelmann S; Togni M; Thielitz A; Reichardt P; Kliche S; Reinhold D; Schraven B; Reinhold A J Immunol; 2013 Nov; 191(10):4950-9. PubMed ID: 24101551 [TBL] [Abstract][Full Text] [Related]
7. IL-10 mediates resistance to adoptive transfer experimental autoimmune encephalomyelitis in MyD88(-/-) mice. Cohen SJ; Cohen IR; Nussbaum G J Immunol; 2010 Jan; 184(1):212-21. PubMed ID: 19949074 [TBL] [Abstract][Full Text] [Related]
8. Deficient p75 low-affinity neurotrophin receptor expression does alter the composition of cellular infiltrate in experimental autoimmune encephalomyelitis in C57BL/6 mice. Küst B; Mantingh-Otter I; Boddeke E; Copray S J Neuroimmunol; 2006 May; 174(1-2):92-100. PubMed ID: 16519950 [TBL] [Abstract][Full Text] [Related]
9. CD62L is required for the priming of encephalitogenic T cells but does not play a major role in the effector phase of experimental autoimmune encephalomyelitis. Li O; Liu JQ; Zhang H; Zheng P; Liu Y; Bai XF Scand J Immunol; 2006 Aug; 64(2):117-24. PubMed ID: 16867156 [TBL] [Abstract][Full Text] [Related]
10. TNF-alpha expression by resident microglia and infiltrating leukocytes in the central nervous system of mice with experimental allergic encephalomyelitis. Regulation by Th1 cytokines. Renno T; Krakowski M; Piccirillo C; Lin JY; Owens T J Immunol; 1995 Jan; 154(2):944-53. PubMed ID: 7814894 [TBL] [Abstract][Full Text] [Related]
11. Astrocytic Fas ligand expression is required to induce T-cell apoptosis and recovery from experimental autoimmune encephalomyelitis. Wang X; Haroon F; Karray S; Martina Deckert ; Schlüter D Eur J Immunol; 2013 Jan; 43(1):115-24. PubMed ID: 23011975 [TBL] [Abstract][Full Text] [Related]
12. Experimental allergic encephalomyelitis. T cell trafficking to the central nervous system in a resistant Thy-1 congenic mouse strain. Skundric DS; Huston K; Shaw M; Tse HY; Raine CS Lab Invest; 1994 Nov; 71(5):671-9. PubMed ID: 7526038 [TBL] [Abstract][Full Text] [Related]
13. IL-6-deficient mice are resistant to experimental autoimmune encephalomyelitis: roles of IL-6 in the activation and differentiation of autoreactive T cells. Samoilova EB; Horton JL; Hilliard B; Liu TS; Chen Y J Immunol; 1998 Dec; 161(12):6480-6. PubMed ID: 9862671 [TBL] [Abstract][Full Text] [Related]
14. Induction of the genes for Cxcl9 and Cxcl10 is dependent on IFN-gamma but shows differential cellular expression in experimental autoimmune encephalomyelitis and by astrocytes and microglia in vitro. Carter SL; Müller M; Manders PM; Campbell IL Glia; 2007 Dec; 55(16):1728-39. PubMed ID: 17902170 [TBL] [Abstract][Full Text] [Related]
15. Decoy receptor 3 ameliorates experimental autoimmune encephalomyelitis by directly counteracting local inflammation and downregulating Th17 cells. Chen SJ; Wang YL; Kao JH; Wu SF; Lo WT; Wu CC; Tao PL; Wang CC; Chang DM; Sytwu HK Mol Immunol; 2009 Dec; 47(2-3):567-74. PubMed ID: 19819554 [TBL] [Abstract][Full Text] [Related]
16. Critical role of antigen-specific antibody in experimental autoimmune encephalomyelitis induced by recombinant myelin oligodendrocyte glycoprotein. Lyons JA; Ramsbottom MJ; Cross AH Eur J Immunol; 2002 Jul; 32(7):1905-13. PubMed ID: 12115610 [TBL] [Abstract][Full Text] [Related]
17. Decreased severity of experimental autoimmune encephalomyelitis during resveratrol administration is associated with increased IL-17+IL-10+ T cells, CD4(-) IFN-gamma+ cells, and decreased macrophage IL-6 expression. Imler TJ; Petro TM Int Immunopharmacol; 2009 Jan; 9(1):134-43. PubMed ID: 19022403 [TBL] [Abstract][Full Text] [Related]
18. Elevated interferon gamma expression in the central nervous system of tumour necrosis factor receptor 1-deficient mice with experimental autoimmune encephalomyelitis. Wheeler RD; Zehntner SP; Kelly LM; Bourbonnière L; Owens T Immunology; 2006 Aug; 118(4):527-38. PubMed ID: 16780563 [TBL] [Abstract][Full Text] [Related]
19. Behavioral and pathological outcomes in MOG 35-55 experimental autoimmune encephalomyelitis. Jones MV; Nguyen TT; Deboy CA; Griffin JW; Whartenby KA; Kerr DA; Calabresi PA J Neuroimmunol; 2008 Aug; 199(1-2):83-93. PubMed ID: 18582952 [TBL] [Abstract][Full Text] [Related]
20. IFN-gamma is critical to the control of murine autoimmune encephalomyelitis and regulates both in the periphery and in the target tissue: a possible role for nitric oxide. Willenborg DO; Fordham SA; Staykova MA; Ramshaw IA; Cowden WB J Immunol; 1999 Nov; 163(10):5278-86. PubMed ID: 10553050 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]